Analyst Ratings for Astrana Health, Inc (ASTH)
ASTH Rating Summary
ASTH Price Target Summary
- Highest: $37.00 (Truist Securities)
- Lowest: $26.00 (Barclays)
- Average: $33.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$33.00 (+32.5%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Avg. $ Target:
$33.00 (+32.5%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/12/2025 | Needham » Updated 3/2/2026 |
Matthew Shea | New Coverage | Buy (N/A) |
30.00 (N/A) |
22.46 (24.91) |
10.91% | Details |
| 4/1/2025 | Barclays » Updated 11/24/2025 |
Andrew Mok | New Coverage | Equalweight (N/A) |
26.00 (36.00) |
31.01 (24.91) |
-19.67% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
